BISCHOFBERGER NORBERT W 13D and 13G filings for Kronos Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-02 9:01 pm Sale |
2024-06-28 | 13D | Kronos Bio, Inc. KRON |
BISCHOFBERGER NORBERT W | 12,681,108 21.100% |
-1,470,834 (-10.39%) |
Filing |
| 2024-06-12 7:32 pm Purchase |
2024-06-10 | 13D | Kronos Bio, Inc. KRON |
BISCHOFBERGER NORBERT W | 14,151,942 23.600% |
3,527,205 (+33.20%) |
Filing |
| 2023-11-27 4:41 pm Purchase |
2023-11-15 | 13D | Kronos Bio, Inc. KRON |
BISCHOFBERGER NORBERT W | 10,624,737 17.400% |
4,689,577 (+79.01%) |
Filing |
| 2022-02-17 4:14 pm Purchase |
2021-12-31 | 13G | Kronos Bio, Inc. KRON |
BISCHOFBERGER NORBERT W | 5,935,160 10.500% |
14,356 (+0.24%) |
Filing |
| 2021-05-04 4:01 pm Purchase |
2020-12-31 | 13G | Kronos Bio, Inc. KRON |
BISCHOFBERGER NORBERT W | 5,920,804 10.600% |
5,920,804 (New Position) |
Filing |